[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"perinatal-substance-use\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:perinatal-substance-use":25},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,42],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":30,"whyStopped":4,"lastUpdateSubmitDate":31,"lastUpdatePostDateStruct":32,"startDateStruct":35,"completionDateStruct":37,"leadSponsor":39,"locationsCount":5},"100642931","digitally-enhanced-peer-doula-model-for-perinatal-patients-with-substance-use-disorder-100642931",false,"NCT07642947","Digitally Enhanced Peer Doula Model for Perinatal Patients With Substance Use Disorder","A Digitally Enhanced Model of Peer Doula Support for Substance Use Disorder and Peripartum Care","EMBRACE","Staff Participant\n\nInclusion Criteria:\n\n1. 18 years of age or older.\n2. Employed by the participating clinic site and identified as care providers and\u002For administrative staff. Clinic roles may include:\n\n   1. Provider (including MD, CNM, DO, PA, NP, nurse, medical assistant, behavioral health clinician, social worker, lactation consultant and\u002For other clinical roles that provide care to patients).\n   2. Peer doulas.\n   3. Administrator (including front desk staff, scheduler, clinic and\u002For team manager).\n   4. Site leadership.\n3. Able to speak English sufficiently to understand the study and, having understood, provide written informed consent to participate in the study.\n\nExclusion Criteria:\n\n1. Unwilling or unable to provide consent\n2. Currently detained in jail, prison, residential substance use treatment facility, or other overnight facility as required by court of law; or have pending legal action that could prevent participating in study activities\n\nPatient Participant (Cohort 1 \\& Cohort 2)\n\nInclusion Criteria\n\n1. 18 years of age or older\n2. Patient of the participating site who is eligible to receive prenatal, postpartum, or delivery services\n\n   •Either\n   1. Not currently engaged in the digitally enhanced peer doula model and no prior exposure to the model or less than 30 days exposure to the model if newly enrolled, AND currently pregnant or up to 6 weeks postpartum.\n\n      OR\n   2. Currently engaged in the digitally enhanced peer doula model for more than 30 days, AND currently pregnant or up to one year postpartum\n3. Able to speak English sufficiently to understand the study and, having understood, provide written informed consent to participate in the study.\n\nExclusion Criteria:\n\n1. Unable or unwilling to provide consent to participate in study activities\n2. Currently detained in jail, prison, residential substance use treatment facility, or other overnight facility as required by court of law; or have pending legal action that could prevent participating in study activities\n3. Currently unable to engage in the digitally enhanced peer doula model or attend research visits","ALL","18 Years",{"count":20,"type":21},100,"ESTIMATED","OBSERVATIONAL","The goal of this pilot study is to learn if a digitally enhanced peer doula program for people with perinatal substance use disorders (PSUD) is feasible and acceptable to patients and staff at two clinics.\n\nParticipants will include staff members, such as healthcare providers, recovery support doulas, and administrators, who work at one of the two clinics. It will also include PSUD patients receiving care through the digitally enhanced peer doula program.\n\nParticipants will be asked to complete short surveys and take part in a one-time interview with research staff.\n\nThis study will also explore engagement in perinatal substance use disorder treatment and prenatal and postpartum visits.",[25],"Perinatal Substance Use",[27,28,29],"Peer Doula","Perinatal Substance Use Disorder","Digital Model of Care","NOT_YET_RECRUITING","2026-06-09",{"date":33,"type":34},"2026-06-11","ACTUAL",{"date":36,"type":21},"2026-06-01",{"date":38,"type":21},"2027-02-28",{"name":40,"class":41},"Trustees of Dartmouth College","OTHER",{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":49,"minAge":18,"maxAge":4,"enrollmentInfo":50,"targetDuration":4,"studyType":52,"phases":53,"briefSummary":55,"conditions":56,"keywords":4,"overallStatus":59,"whyStopped":4,"lastUpdateSubmitDate":60,"lastUpdatePostDateStruct":61,"startDateStruct":63,"completionDateStruct":65,"leadSponsor":67,"locationsCount":69},"100598459","improving-outcomes-for-early-postpartum-mothers-in-outpatient-moud-treatment-100598459","NCT07071766","Improving Outcomes for Early Postpartum Mothers in Outpatient MOUD Treatment","Adaptation and Implementation of an Evidence-Based Parenting Intervention for Postpartum Women Receiving Medications for Opioid Use Disorder","Inclusion Criteria:\n\n* 18 years or older\n* Understand and speak English\n* Able to give informed consent\n* Receiving medications for opioid use disorder in the outpatient clinical setting\n* Between 28 weeks gestation and up to 12 months postpartum\n\nExclusion Criteria:\n\n* Unwilling to consent\n* Before 28 weeks gestation and beyond 12 months postpartum at enrollment","FEMALE",{"count":51,"type":21},10,"INTERVENTIONAL",[54],"NA","Drug overdose is a leading cause of death among postpartum women and opioid-related mortality is 4 times higher in the postpartum period when compared to the third trimester of pregnancy. Medications for opioid use disorder (MOUD; e.g., methadone or buprenorphine) are the recommended standard of care for perinatal women with OUD. Studies indicate that 50-60% of perinatal women with OUD initiate medications during pregnancy; however, over half will prematurely discontinue treatment within the first six months of childbirth due to stressors experienced in the postpartum period. Common stressors that contribute to MOUD treatment discontinuation in this population are return to opioid use, mental health symptoms including depression, parenting-related stressors such as challenges in infant care and bonding, Neonatal Abstinence Syndrome (NAS), child welfare involvement, and feelings of guilt, shame, and stigma. Thus, there is an urgent need to develop effective, recovery-oriented support interventions that promote the initiation and continuity of MOUD treatment in the postpartum period. The current study utilizes community-engaged research methods to identify and prioritize the early parenting-related needs of postpartum women receiving MOUD to inform the adaptation and implementation of an evidence-based parenting intervention for this population receiving outpatient treatment for opioid use disorder.",[57,25,58],"Substance Use Treatment","Parenting","RECRUITING","2026-06-02",{"date":62,"type":34},"2026-06-03",{"date":64,"type":21},"2026-07-01",{"date":66,"type":21},"2027-06-30",{"name":68,"class":41},"University of Arkansas",1]